PKD Parents Community Meeting: Tolvaptan Use in Pediatric ADPKD and ARPKD

In 2018, the U.S. Food and Drug Administration (FDA) approved tolvaptan as the first treatment for adult patients with ADPKD in the U.S. Join us to learn about the use of tolvaptan to treat ADPKD and ARPKD in children. Katherine Dell, M.D., Pediatric Nephrologist at PKD Foundation Pediatric Center of Excellence, Cleveland Clinic Children’s, will lead our discussion and answer your questions. Mara, a PKD parent, will join us to share her family’s experience participating in clinical trials and the impact it has had on their daughter’s journey with PKD..